Literature DB >> 3604903

5-Fluorouracil-induced coronary vasospasm.

A J Burger, S Mannino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3604903     DOI： 10.1016/0002-8703(87)90517-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  10 in total

1.  Intramural myocardial infarction under combined radiochemotherapy of an oesophageal carcinoma.

Authors:  E Höring; B Neef; U von Gaisberg
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.

Authors:  J A Casas; P A Saway; I Villarreal; C Nolte; B L Menajovsky; E E Escudero; W D Blackburn; G S Alarcón; C P Subauste
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 3.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

4.  Induction chemotherapy followed by simultaneous hyperfractionated radiochemotherapy in advanced head and neck cancer. A pilot study.

Authors:  B Jereczek-Fossa; F De Braud; M Gasparetto; T De Pas; N Tradati; M C Leonardi; H R Marsiglia; R Orecchia
Journal:  Strahlenther Onkol       Date:  1998-09       Impact factor: 3.621

5.  5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels.

Authors:  Taflan Salepci; Mesut Seker; Huseyin Uyarel; Mahmut Gumus; Ahmet Bilici; Bala Basak Oven Ustaalioğlu; Akin Oztürk; Berkant Sonmez; Asuman Orcun; Mustafa Ozates; Rahmi Irmak; Mustafa Yaylaci
Journal:  Med Oncol       Date:  2009-05-05       Impact factor: 3.064

Review 6.  Cardiotoxicity and oncological treatments.

Authors:  Axel Schlitt; Karin Jordan; Dirk Vordermark; Jürgen Schwamborn; Thorsten Langer; Christoph Thomssen
Journal:  Dtsch Arztebl Int       Date:  2014-03-07       Impact factor: 5.594

7.  Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.

Authors:  C H Köhne; P Thuss-Patience; M Friedrich; P T Daniel; A Kretzschmar; T Benter; B Bauer; R Dietz; B Dörken
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

8.  Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?

Authors:  Jun Chong; Andrew Fw Ho; Jonathan Yap; Heerajnarain Bulluck; Derek J Hausenloy
Journal:  Cond Med       Date:  2019-10

Review 9.  5-fluorouracil and cardiotoxicity: a review.

Authors:  Jaskanwal D Sara; Jasvinder Kaur; Ryan Khodadadi; Muneeb Rehman; Ronstan Lobo; Sakti Chakrabarti; Joerg Herrmann; Amir Lerman; Axel Grothey
Journal:  Ther Adv Med Oncol       Date:  2018-06-18       Impact factor: 8.168

Review 10.  Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission.

Authors:  Andrea Montisci; Vittorio Palmieri; Jennifer E Liu; Maria T Vietri; Silvia Cirri; Francesco Donatelli; Claudio Napoli
Journal:  Front Cardiovasc Med       Date:  2021-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.